Table of Contents Author Guidelines Submit a Manuscript
Parkinson’s Disease
Volume 2016, Article ID 9539836, 6 pages
http://dx.doi.org/10.1155/2016/9539836
Research Article

Parkinson’s Disease and Homocysteine: A Community-Based Study in a Folate and Vitamin B12 Deficient Population

Department of Neurology, First Hospital, Shanxi Medical University, No. 85, Jiefang Nan Street, Yingze District, Taiyuan 030000, China

Received 28 May 2016; Accepted 7 August 2016

Academic Editor: Hélio Teive

Copyright © 2016 Zhang Wei et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Wirdefeldt, H.-O. Adami, P. Cole, D. Trichopoulos, and J. Mandel, “Epidemiology and etiology of Parkinson's disease: a review of the evidence,” European Journal of Epidemiology, vol. 26, supplement 1, pp. S1–S58, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. E. R. Dorsey, R. Constantinescu, J. P. Thompson et al., “Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030,” Neurology, vol. 68, no. 5, pp. 384–386, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. L. C. S. Tan, N. Venketasubramanian, C. Y. Hong et al., “Prevalence of Parkinson disease in Singapore: Chinese vs Malays vs Indians,” Neurology, vol. 62, no. 11, pp. 1999–2004, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. B. S. Schoenberg, B. O. Osuntokun, A. O. G. Adeuja et al., “Comparison of the prevalence of Parkinson’s disease in black populations in the rural United States and in rural Nigeria: door-to-door community studies,” Neurology, vol. 38, no. 4, pp. 645–646, 1988. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Checkoway and L. M. Nelson, “Epidemiologic approaches to the study of Parkinson's disease etiology,” Epidemiology, vol. 10, no. 3, pp. 327–336, 1999. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Clarke, L. Daly, K. Robinson et al., “Hyperhomocysteinemia: an independent risk factor for vascular disease,” The New England Journal of Medicine, vol. 324, no. 17, pp. 1149–1155, 1991. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Clarke, A. D. Smith, K. A. Jobst, H. Refsum, L. Sutton, and P. M. Ueland, “Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease,” Archives of Neurology, vol. 55, no. 11, pp. 1449–1455, 1998. View at Publisher · View at Google Scholar · View at Scopus
  8. N. K. Kim, B. O. Choi, W. S. Jung, Y. J. Choi, and K. G. Choi, “Hyperhomocysteinemia as an independent risk factor for silent brain infarction,” Neurology, vol. 61, no. 11, pp. 1595–1599, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Zoccolella, C. dell'Aquila, L. M. Specchio, G. Logroscino, and P. Lamberti, “Elevated homocysteine levels in Parkinson's disease: is there anything besides L-dopa treatment?” Current Medicinal Chemistry, vol. 17, no. 3, pp. 213–221, 2010. View at Google Scholar
  10. E. F. dos Santos, E. N. B. Busanello, A. Miglioranza et al., “Evidence that folic acid deficiency is a major determinant of hyperhomocysteinemia in Parkinson's disease,” Metabolic Brain Disease, vol. 24, no. 2, pp. 257–269, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. F. Blandini, R. Fancellu, E. Martignoni et al., “Plasma homocysteine and L-DOPA metabolism in patients with Parkinson disease,” Clinical Chemistry, vol. 47, no. 6, pp. 1102–1104, 2001. View at Google Scholar · View at Scopus
  12. B. Wang, J. Huo, J. Huang, and J. Sun, “Total diet study on certain nutrients in Shanxi regions with a high incidence of birth defects,” Wei Sheng Yan Jiu, vol. 37, no. 6, pp. 702–706, 2008. View at Google Scholar · View at Scopus
  13. Y. Wang, X. Li, X. Qin et al., “Prevalence of hyperhomocysteinaemia and its major determinants in rural Chinese hypertensive patients aged 45–75 years,” British Journal of Nutrition, vol. 109, no. 7, pp. 1284–1293, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. Reginal Development and Life Index Reports of 2011, National Bureau of Statistics of China, Beijing, China, 2013, http://www.stats.gov.cn/tjsj/zxfb/201412/t20141231_661933.html.
  15. Z. Wei, N. Xiaoyuan, G. Shengwei, H. Zhizong, L. Jiyuan, and L. Yang, “Evaluation of a screening questionnaire for Parkinson's disease in a Chinese population,” Journal of Clinical Neuroscience, vol. 21, no. 2, pp. 278–281, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Fahn and R. L. Elton, Recent Developments in Parkinson's Disease, vol. 2, MacMillan Healthcare Information, Florham Park, NJ, USA, 1987.
  17. A. J. Hughes, S. E. Daniel, L. Kilford, and A. J. Lees, “Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases,” Journal of Neurology, Neurosurgery & Psychiatry, vol. 55, no. 3, pp. 181–184, 1992. View at Publisher · View at Google Scholar · View at Scopus
  18. M. M. Hoehn and M. D. Yahr, “Parkinsonism: onset, progression, and mortality,” Neurology, vol. 17, no. 5, pp. 427–442, 1967. View at Publisher · View at Google Scholar · View at Scopus
  19. R. C. Chen, S. F. Chang, C. L. Su et al., “Prevalence, incidence, and mortality of PD: a door-to-door survey in Ilan County, Taiwan,” Neurology, vol. 57, no. 9, pp. 1679–1686, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. W. Zhang, Y. Li, T. D. Wang et al., “Nutritional status of the elderly in rural North China: a cross-sectional study,” Journal of Nutrition, Health and Aging, vol. 18, no. 8, pp. 730–736, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. Z.-X. Zhang, G. C. Roman, Z. Hong et al., “Parkinson's disease in China: prevalence in Beijing, Xian, and Shanghai,” The Lancet, vol. 365, no. 9459, pp. 595–597, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. M. C. de Rijk, C. Tzourio, M. M. Breteler et al., “Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative study. European Community Concerted Action on the Epidemiology of Parkinson's disease,” Journal of Neurology, Neurosurgery & Psychiatry, vol. 62, no. 1, pp. 10–15, 1997. View at Google Scholar
  23. J. Benito-León, F. Bermejo-Pareja, J. Rodríguez, J.-A. Molina, R. Gabriel, and J.-M. Morales, “Prevalence of PD and other types of parkinsonism in three elderly populations of central Spain,” Movement Disorders, vol. 18, no. 3, pp. 267–274, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. M. T. Barbosa, P. Caramelli, D. P. Maia et al., “Parkinsonism and Parkinson's disease in the elderly: a community-based survey in Brazil (the Bambuí Study),” Movement Disorders, vol. 21, no. 6, pp. 800–808, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. S.-J. Wang, J.-L. Fuh, E. L. Teng et al., “A door-to-door survey of Parkinson's disease in a Chinese population in kinmen,” Archives of Neurology, vol. 53, no. 1, pp. 66–71, 1996. View at Publisher · View at Google Scholar · View at Scopus
  26. L. Hao, J. Ma, J. Zhu et al., “High prevalence of hyperhomocysteinemia in Chinese adults is associated with low folate, vitamin B-12, and vitamin B-6 status,” Journal of Nutrition, vol. 137, no. 2, pp. 407–413, 2007. View at Google Scholar · View at Scopus
  27. S. Özkan, Ö. Colak, C. Kutlu, M. Ertan, and Ö. Alatas, “Plasma homocysteine levels in pergolide-treated Parkinson disease patients,” Clinical Neuropharmacology, vol. 27, no. 4, pp. 163–165, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. T. Müller, B. Werne, B. Fowler, and W. Kuhn, “Nigral endothelial dysfunction, homocysteine, and Parkinson's disease,” The Lancet, vol. 354, no. 9173, pp. 126–127, 1999. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Zoccolella, P. Lamberti, E. Armenise et al., “Plasma homocysteine levels in Parkinson's disease: role of antiparkinsonian medications,” Parkinsonism and Related Disorders, vol. 11, no. 2, pp. 131–133, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. D. Religa, K. Czyzewski, M. Styczynska et al., “Hyperhomocysteinemia and methylenetetrahydrofolate reductase polymorphism in patients with Parkinson's disease,” Neuroscience Letters, vol. 404, no. 1-2, pp. 56–60, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. Z. Todorović, E. Džoljić, I. Novaković et al., “Homocysteine serum levels and MTHFR C677T genotype in patients with Parkinson's disease, with and without levodopa therapy,” Journal of the Neurological Sciences, vol. 248, no. 1-2, pp. 56–61, 2006. View at Publisher · View at Google Scholar
  32. X.-W. Hu, S.-M. Qin, D. Li, L.-F. Hu, and C.-F. Liu, “Elevated homocysteine levels in levodopa-treated idiopathic Parkinson's disease: a meta-analysis,” Acta Neurologica Scandinavica, vol. 128, no. 2, pp. 73–82, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Grandinetti, D. M. Morens, D. Reed, and D. MacEachern, “Prospective study of cigarette smoking and the risk of developing idiopathic Parkinson's disease,” American Journal of Epidemiology, vol. 139, no. 12, pp. 1129–1138, 1994. View at Google Scholar · View at Scopus
  34. J. M. Gorell, B. A. Rybicki, C. C. Johnson, and E. L. Peterson, “Smoking and Parkinson's disease: a dose-response relationship,” Neurology, vol. 52, no. 1, pp. 115–119, 1999. View at Publisher · View at Google Scholar · View at Scopus
  35. H. Chen, S. M. Zhang, M. A. Schwarzschild et al., “Folate intake and risk of Parkinson's disease,” American Journal of Epidemiology, vol. 160, no. 4, pp. 368–375, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. L. M. L. de Lau, P. J. Koudstaal, J. C. M. Witteman, A. Hofman, and M. M. B. Breteler, “Dietary folate, vitamin B12, and vitamin B6 and the risk of Parkinson disease,” Neurology, vol. 67, no. 2, pp. 315–318, 2006. View at Publisher · View at Google Scholar · View at Scopus